NO20066005L - Injiserbar farmasoytisk suspensjon omfattende posaconazol - Google Patents

Injiserbar farmasoytisk suspensjon omfattende posaconazol

Info

Publication number
NO20066005L
NO20066005L NO20066005A NO20066005A NO20066005L NO 20066005 L NO20066005 L NO 20066005L NO 20066005 A NO20066005 A NO 20066005A NO 20066005 A NO20066005 A NO 20066005A NO 20066005 L NO20066005 L NO 20066005L
Authority
NO
Norway
Prior art keywords
posaconazole
injectable pharmaceutical
pharmaceutical suspension
configurations
suspension
Prior art date
Application number
NO20066005A
Other languages
English (en)
Inventor
Sydney Ugwu
Leonore Witchey-Lakshmanan
Varda Sandweiss
Catherine Hardalo
Roberta S Hare
Gopal Krishna
Zaiqi Wang
Marco Taglietti
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34971355&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20066005(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO20066005L publication Critical patent/NO20066005L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer utforminger som er anvendbare for behandling av infeksjoner, nærmere bestemt utforminger som omfatter den aktive farmasøytiske bestanddel posakonazol i en injiserbar suspensjon som er stabil når den behandles ved avsluttende dampsterilisering. Fig. 4
NO20066005A 2004-05-28 2006-12-22 Injiserbar farmasoytisk suspensjon omfattende posaconazol NO20066005L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57512604P 2004-05-28 2004-05-28
PCT/US2005/018945 WO2005117831A1 (en) 2004-05-28 2005-05-27 Injectable pharmaceutical suspension comprising posaconazole

Publications (1)

Publication Number Publication Date
NO20066005L true NO20066005L (no) 2007-02-27

Family

ID=34971355

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20066005A NO20066005L (no) 2004-05-28 2006-12-22 Injiserbar farmasoytisk suspensjon omfattende posaconazol

Country Status (15)

Country Link
EP (1) EP1761247A1 (no)
JP (1) JP2008501034A (no)
KR (1) KR20070027564A (no)
CN (1) CN1988887A (no)
AR (1) AR049063A1 (no)
AU (1) AU2005249502A1 (no)
CA (1) CA2567803A1 (no)
IL (1) IL179627A0 (no)
MX (1) MXPA06013886A (no)
NO (1) NO20066005L (no)
PE (1) PE20060291A1 (no)
RU (1) RU2006146555A (no)
TW (1) TWI290051B (no)
WO (1) WO2005117831A1 (no)
ZA (1) ZA200609890B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060009469A1 (en) * 2004-05-28 2006-01-12 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmacutical compositions of posaconazole
RS56044B1 (sr) 2006-05-12 2017-09-29 Christian Noe Primena kombinovanih preparata koji sadrže antimikotike
EP2130540A1 (en) * 2008-06-02 2009-12-09 Sandoz AG Pharmaceutical compositions containing a crystalline form of posaconazole
EP2141159A1 (en) 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
WO2011003992A1 (en) 2009-07-09 2011-01-13 Sandoz Ag A crystalline form of posaconazole
WO2011144655A1 (en) 2010-05-19 2011-11-24 Sandoz Ag Process for the preparation of chiral hydrazides
EP2571869B1 (en) 2010-05-19 2015-09-23 Sandoz AG Purification of posaconazole and posaconazole intermediates
CA2798002C (en) 2010-05-19 2019-12-03 Sandoz Ag Process for the preparation of chiral triazolones
EP2571868B1 (en) 2010-05-19 2016-05-04 Sandoz AG Preparation of posaconazole intermediates
BR112012033077B8 (pt) * 2010-06-29 2023-04-25 Merck Sharp & Dohme Composição farmacêutica para administração intravenosa, uso de uma composição farmacêutica, e, kit
CN108329303A (zh) 2011-06-16 2018-07-27 桑多斯股份公司 制备手性化合物的方法
CN103284959B (zh) * 2012-02-22 2015-06-03 重庆圣华曦药业股份有限公司 泊沙康唑冻干粉针剂及制备方法
CN102755628B (zh) * 2012-07-16 2013-10-23 中国科学院微生物研究所 一种抗真菌的药物组合物
CN102805731B (zh) * 2012-08-22 2014-04-30 北京莱瑞森医药科技有限公司 泊沙康唑干混悬剂及其制备方法
CN105030668B (zh) * 2015-06-26 2018-03-27 济川药业集团有限公司 泊沙康唑口服混悬剂及其制备方法
CN106333925B (zh) * 2015-07-10 2019-06-18 上海美悦生物科技发展有限公司 一种泊沙康唑液体混悬剂及其制备方法
CN105997872B (zh) * 2016-07-08 2019-02-19 河南省立眼科医院 一种含有泊沙康唑的眼用纳米胶束抗真菌溶液
CN110582264B (zh) * 2017-03-26 2022-11-11 V·R·斯塔福德 眼睑皮肤状况的处理方法
EP3609329A4 (en) * 2017-04-12 2021-03-17 Bhagwandin, Vikash J. COMPOSITIONS, PACKAGED MEDICINAL PRODUCTS AND METHODS OF USE OF POSACONAZOLE FOR RESISTANT TUMORS Awareness
CN110507609B (zh) * 2018-05-21 2021-09-17 上海医药工业研究院 泊沙康唑口服混悬剂的制备方法
CN111514146A (zh) * 2020-04-28 2020-08-11 山西振东泰盛制药有限公司 含有泊沙康唑的药物组合物
CN113933131B (zh) * 2021-09-24 2024-01-26 合肥天一生物技术研究所有限责任公司 一种阴道微生物荧光染色液

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091188A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
CA2443089C (en) * 2001-04-03 2011-11-01 Schering Corporation Antifungal suspension of micronized posaconazole

Also Published As

Publication number Publication date
EP1761247A1 (en) 2007-03-14
KR20070027564A (ko) 2007-03-09
RU2006146555A (ru) 2008-07-20
MXPA06013886A (es) 2007-01-26
CA2567803A1 (en) 2005-12-15
AU2005249502A1 (en) 2005-12-15
IL179627A0 (en) 2007-05-15
AR049063A1 (es) 2006-06-21
TW200609001A (en) 2006-03-16
ZA200609890B (en) 2008-09-25
TWI290051B (en) 2007-11-21
JP2008501034A (ja) 2008-01-17
WO2005117831A1 (en) 2005-12-15
PE20060291A1 (es) 2006-04-14
CN1988887A (zh) 2007-06-27

Similar Documents

Publication Publication Date Title
NO20066005L (no) Injiserbar farmasoytisk suspensjon omfattende posaconazol
EA200800798A1 (ru) Фармацевтические композиции, предназначенные для лечения нарушений внутреннего уха
NO20080338L (no) Forbindelser for behandling av multilegemiddelresistente bakterielle infeksjoner
MD3880197T2 (ro) Metode de tratament pentru fibroză chistică
NO20076675L (no) Aminopiperidinquinoliner og deres azaisosteriske analoger med antibakteriell aktivitet
ECSP056229A (es) Una composición farmacéutica que comprende formas polimórficas de 3-(4-amino-1-oxo-1.3 dyhidro-isoindol-2-il)-piperidina-2,6-diona para el tratamiento y manejo de cánceres
CY1113963T1 (el) Φαρμακευτικες συνθεσεις οι οποιες περιλαμβανουν ανταγωνιστες ακτιβινης-actriia και χρηση αυτων στην προληψη η' θεραπευτικη αγωγη πολλαπλου μυελωματος
TW200602093A (en) Sterilization/disinfection cycle control
BRPI0508540B8 (pt) composto, composição farmacêutica, e, uso de um composto
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
NO20084749L (no) Organiske forbindelser og deres anvendelser
AR052955A1 (es) Producto de combinacion de o- desmetilvanlafaxina y bazedoxifeno y usos del mismo
CL2007002671A1 (es) Compuestos derivados de octahidro-pirrolo[3,4-c]pirrol; composicion farmaceutica que la comprende; y uso del compuesto en el tratamiento del vih, sida o arc.
CR20110267A (es) Tratamiento de transtornos cognitivos con (r)-7-cloro-n-(quinuclidin-3-il) benzo[]tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma
MX2008008556A (es) Derivados de triterpenoquinonas y triterpenofenoles y su aplicacion para el tratamiento de tumores y enfermedades parasitarias.
DK1763339T3 (da) Orale antimikrobielle farmaceutiske præparater
NO20074850L (no) Oftalmologiske sammensetninger og anvendelse derav
HRP20080413T3 (en) Medicament for the treatment of fungal infections, particularly aspergillosis
AR034493A1 (es) Combinacion de principios activos para el tratamiento medico de toxicomanias.
PA8597501A1 (es) Derivados azabiciclicos de piridiloximetilo y bencisoxazol
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
EA200900269A1 (ru) Лекарственные комбинации для лечения заболеваний дыхательных путей
TW200638942A (en) Therapeutic agent
CR9074A (es) Agente para la profilaxis o tratamiento del sindrome metabolico
DE602006017220D1 (de) Ethanolaminsalz von n-(methoxy-5-methylpyrazin-2-yl)-2-(4-ä1,3,4-oxadiazol-2-ylüphenyl)pyridin-3-sulfonamid

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application